Page last updated: 2024-09-05

sorafenib and B-Cell Leukemia

sorafenib has been researched along with B-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, Y; Chen, S; Hong, Y; Sun, A; Tian, X; Xiang, X; Yu, Y; Zeng, Z; Zhang, L	1

Other Studies

1 other study(ies) available for sorafenib and B-Cell Leukemia

Article	Year
Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib. BMC cancer, 2021, Dec-14, Volume: 21, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents; Apoptosis; Child; Cluster Analysis; Female; Ferroptosis; Humans; Leukemia, B-Cell; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Risk Factors; RNA-Seq; Sorafenib; Treatment Outcome; Tumor Microenvironment; Unsupervised Machine Learning; Young Adult	2021

Article

Year

Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib.

BMC cancer, 2021, Dec-14, Volume: 21, Issue:1

Topics: Adolescent; Adult; Antineoplastic Agents; Apoptosis; Child; Cluster Analysis; Female; Ferroptosis; Humans; Leukemia, B-Cell; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Risk Factors; RNA-Seq; Sorafenib; Treatment Outcome; Tumor Microenvironment; Unsupervised Machine Learning; Young Adult

2021